Document:

EX-10.6.2

 Exhibit 10.6.2 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT 

PharMEDium Services, LLC (the “Company”) and William R. Spalding (“Executive”) have entered into that
certain Employment Agreement, dated April 23, 2013 (the “Employment Agreement”). The Company and Executive wish to amend the Employment Agreement pursuant to this First Amendment to the Employment Agreement (the
“Amendment”), on December 31, 2013 (the “Effective Date”). 
 WHEREAS, Executive is currently
employed by the Company pursuant to the terms of the Employment Agreement. 
 WHEREAS, the Employment Agreement may be amended pursuant to
Section 14(g) thereof. 
 WHEREAS, the Company desires to retain Executive as an employee of the Company upon the terms of the
Employment Agreement, as amended by this Amendment. 
 WHEREAS, the Company is a party to that certain Agreement and Plan of Merger, by and
among the Company, CDRF Parent, Inc., a Delaware corporation (“Parent”), CDRF Merger Sub, Inc., a Delaware Corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and certain other parties, dated
December 17, 2013 (the “Merger Agreement”), pursuant to which Merger Sub will merge with and into the Company (the “Merger”). 

WHEREAS, the effectiveness of this Amendment is subject to and conditioned upon the consummation of the Merger (the
“Closing”). 
 NOW, THEREFORE, in exchange for the promises and mutual covenants contained in the Employment Agreement and
this Amendment, the Company and Executive, intending to be legally bound, agree as follows, effective as of the Effective Date, subject to the occurrence of the Closing: 

1. Section 1(b) of the Employment Agreement is hereby amended to replace the sentence “However, in no event shall the date upon which
Executive is transitioned into the position of CEO be later than December 31, 2013.” in its entirety with the following: 

“Executive shall become CEO on the Closing Date, ‘Closing Date’ means the consummation of the merger contemplated by that
certain Agreement and Plan of Merger, by and among PharMedium Healthcare Corporation (“PharMedium”), CDRF Parent, Inc., a Delaware corporation (‘Parent’), CDRF Merger Sub, Inc., a Delaware Corporation and a wholly owned
subsidiary of Parent (“Merger Sub”), and certain other parties, dated December 17, 2013, pursuant to which Merger Sub will merge with and into the PharMedium.” 

 2. The Employment Agreement is hereby amended to replace Section 3(h) in its entirety with
the following; 
 “(i) General. The Agreement and any payments provided hereunder are intended to comply with, or
be exempt from, §409A of the Code (including any valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder). The Agreement shall in all respects be interpreted,
operated, and administered in accordance with this intent. Payments provided under the Agreement may only be made upon an event and in a manner that complies with §409A of the Code or an applicable exemption, including to the maximum extent
possible, exemptions for separation pay due to an involuntary separation from service and/or short-term deferrals. Any payments provided under the Agreement to be made upon a termination of service that constitute deferred compensation subject to
§409A of the Code shall only be made if such termination of service constitutes a ‘separation from service’ under §409A of the Code. Each installment payment provided under the Agreement shall be treated as a separate identified
payment for purposes of §409A of the Code. If Executive is a ‘specified employee’ under §409A of the Code at the time of Executive’s termination of service, any payments to be made upon a termination of service that
constitute deferred compensation subject to §409A of the Code and that are scheduled to be made within six months following Executive’s termination date shall be delayed, without interest, and paid in a lump sum on the earlier of
(1) the first payroll date to occur following the six-month anniversary of Executive’s termination date, or (2) Executive’s death, and any payments otherwise scheduled to be made thereafter shall be made in accordance with their
original schedule. 
 (ii) Taxable Reimbursements. To the extent required by §409A of the Code, each
reimbursement or in-kind benefit provided under the Agreement shall be provided in accordance with the following: (1) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the
expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year, (2) any reimbursement of an eligible expense shall be paid to Executive on or before the last day of the calendar year following the calendar
year in which the expense was incurred, and (3) any right to reimbursements or in-kind benefits under the Agreement shall not be subject to liquidation or exchange for another benefit.” 

3. Clause i) of Section 4(d) of the Employment Agreement is hereby amended to replace the phrase “on or before December 31,
2013” with “on the Closing Date.” 

  
 2 

 4. The Employment Agreement is hereby amended to replace Section 5(b) in its entirety with
the following: 
 “(b) If Executive is entitled to the Severance Package under Section 5(a), the Base Severance
Amount and Bonus Amount will be paid to Executive in a lump sum reasonably promptly after the Expiration Date, but in no event later than March 15 of the year following the year in which the Expiration Date occurs.” 

5. The effectiveness of this Amendment is subject to and conditioned upon the occurrence of the Closing. If either the Merger Agreement is
terminated prior to the Closing or the Closing otherwise does not occur for any reason, this Amendment shall be null and void and no party shall have any rights or obligations hereunder. 

6. All other terms and conditions of the Employment Agreement shall remain in full force and effect. 

  
 3 

 IN WITNESS WHEREOF, this Amendment is hereby executed by Executive and the Company’s
authorized representative set forth below. 
  

	
	EXECUTIVE
	
	/s/ William R. Spalding
	William R. Spalding
	
	PHARMEDIUM SERVICES, LLC
	
	/s/ David Jonas
	David Jonas
	Chairman and CEO

  
 [signature page to William Spalding
employment agreement amendment]EX-10.7

 Exhibit 10.7 

EMPLOYMENT AGREEMENT 
 (NOTE:
BEFORE SIGNING, PROSPECTIVE EMPLOYEES SHOULD READ THE FOLLOWING AGREEMENT IN ITS ENTIRETY, MAKE CERTAIN THAT THEY UNDERSTAND IT AND, IF DESIRED, REVIEW IT WITH THEIR ATTORNEYS AND ADVISORS.) 

In consideration of my employment and the compensation to be paid to me by PharMEDium Healthcare Corporation, PharMEDium Services, LLC or any of its
affiliated companies, and their respective successors or assigns (collectively, “PharMEDium”), I agree as follows: 
  

	1.	For purposes of this agreement: 

  

	 	(a)	“Competing Products” means products, processes, or services of any person or organization other than PharMEDium, in existence or under development, which are substantially the same, may be substituted for, or
applied to substantially the same end use as the products, processes or services sold, conceived or developed by PharMEDium during the time of my employment with PharMEDium. 

 

	 	(b)	“Competing Organization” means persons or organizations, including myself, engaged in, or about to become engaged in, research or development, production, distribution, marketing, providing or selling of a
Competing Product. 

  

	 	(c)	“Confidential Information” means information relating to the present or planned business of PharMEDium which has not been released publicly by authorized representatives of PharMEDium. I understand that
Confidential Information may include, for example, Trade Secrets, Inventions, know-how and products, customer, patient, supplier and competitor information, sales, pricing, cost and financial data, research, development, marketing and sales programs
and strategies, manufacturing, marketing and service techniques, processes and practices, and regulatory strategies. I understand further that Confidential Information also includes all information received by PharMEDium under an obligation of
confidentiality to a third party. “Invention” means procedures, systems, machines, methods, processes, uses, apparatuses, compositions of matter, designs or configurations, computer programs of any kind, or any improvements of the
foregoing, discovered, conceived, reduced to practice, developed, made, or produced, and shall not be limited to the meaning of “Invention” under the United States patent laws. 

	 	(d)	“Items” include documents, reports, drawings, photographs, designs, specifications, formulae, plans, samples, research or development information, prototypes, tools, equipment, proposals, marketing or sales
plans, customer information, customer lists, patient information, regulatory files, financial data, costs, pricing information, supplier information, written, printed or graphic matter, or other information and materials that concern
PharMEDium’s business that come into my possession or about which I have knowledge by reason of my employment. 

  

	 	(e)	“Trade Secrets” include all information known to PharMEDium encompassed in any Item, or in any manufacturing process, method of production, concept or idea, to the extent that such information has not been
released publicly by duly authorized representatives of PharMEDium. 

  

	2.	I will exert my best efforts in the performance of my duties as an employee of PharMEDium and will remain loyal to PharMEDium during the term of my employment. I acknowledge and agree that PharMEDium is my primary
employer and that any secondary employment which may detract from my work with PharMEDium must be approved by a supervisor. I am not presently engaged in, nor shall I, during the term of my employment with PharMEDium, enter into any employment or
agency relationship with any third party whose interests might conflict with those of PharMEDium. I do not presently, nor shall I during the term of my employment with PharMEDium, possess any significant interest, directly, through my family, or
through organizations or trusts controlled by me, in any third party whose interest might conflict with those of PharMEDium. 

  

	3.	Each Item and all Confidential Information that comes into my possession by reason of my employment are the property of PharMEDium and shall not be used by me in any way except in the course of my employment by and for
the benefit of PharMEDium. I will not remove any Item from premises owned or leased by PharMEDium except as my duties shall require, and upon the termination of my employment all Items in my possession or under my control will be turned over to my
supervisor at PharMEDium. 

  

	4.	 I understand that any entrusting of Confidential Information to me by PharMEDium is done in reliance on a confidential relationship arising out of my
employment with PharMEDium. I further understand that Confidential Information that I may acquire or to which I may have access, especially with regard to research and development projects and findings, formulae, designs, formulation, processes, the
identity of suppliers, customers and patients, methods of manufacturer, and cost and pricing data, is of great value to PharMEDium. Accordingly, I will preserve as confidential all Confidential Information that has

  
 2 

	 	
been or may be obtained by me. I will not, without written authority from PharMEDium, use for my own benefit or purposes, or disclose to others, either during my employment or thereafter, except
as required by my employment with PharMEDium, any Confidential Information or any copy or notes made from any item embodying Confidential Information. I understand that my obligations with respect to Confidential Information shall continue even
after termination of my employment with PharMEDium. These restrictions concerning use and disclosure of Confidential Information shall not apply to information which is or becomes publicly known by lawful means, or comes into my possession from
sources not under any obligation of confidentiality to PharMEDium. I further acknowledge that the Illinois Trade Secrets Act and the Uniform Trade Secrets Act which applies to other states impose an obligation on me to maintain the confidentiality
of all PharMEDium business information so long as that information meets the definition of a “trade secret” under ITSA and UTSA. 

  

	5.	Throughout the term of my employment by PharMEDium and for a period of one year thereafter, I will not render services, directly or indirectly, to any Competing Organization within such geographic limits as PharMEDium
and such Competing Organization are, or would be, in actual competition. I understand that services rendered to such Competing Organization in an executive, scientific, administrative, or consulting capacity in connection with Competing Products are
in support of actual competition in various geographic areas and thus fall within the prohibition of this agreement regardless of where such services physically are rendered. 

 

	6.	Throughout the term of my employment by PharMEDium and for a period of one year thereafter, I will not, either directly or indirectly, on my own behalf or on behalf of any other entity, solicit for employment or for an
independent contractor relationship any person who was an employee or independent contractor of PharMEDium at any time during the then immediately preceding six (6) month period. 

 

	7.	I agree that during the course of my employment with PharMEDium that I will not disparage the Company or any of its affiliates, directors, officers or employees in any manner whatsoever and through word of mouth or any
media, including the Internet, newspapers, radio and television, social networking sites and blogs. I further agree that disparaging the Company anonymously will be a violation of this Agreement and that PharMEDium has the right to seek information
regarding the source of any anonymous postings. This prohibition on disparagement shall not only include the business practices of PharMEDium but any personal information about any of the Company’s directors, officers or employees, whether
based on fact, opinion or rumor. I further acknowledge that, even after my employment with PharMEDium ends, publishing of libelous or slanderous information about PharMEDium or any of its officers, directors, employees or affiliates can subject me
to a lawsuit for that publication. 

  
 3 

	8.	Throughout the term of my employment by PharMEDium and at all times thereafter, I will make every effort to contact PharMEDium’s Chief Executive Officer if I am served with a subpoena or other legal process asking
for a deposition, testimony or other statement, or other potential evidence to be used in connection with any lawsuit to which PharMEDium is a party. 

  

	9.	All Inventions related to the present or planned business of PharMEDium, which are conceived or reduced to practice by me, either alone or with others, during the period of my employment or during a period of one year
after termination of such employment, whether or not done during my regular working hours, are the sole property of PharMEDium. 

  

	10.	I will disclose promptly and in writing to PharMEDium, through my supervisor, all Inventions which I may discover, conceive, reduce to practice, develop, make or produce during the term of my employment by PharMEDium,
and I agree to assign to PharMEDium or its nominee all my right, title, and interest in and to such Inventions. I agree not to disclose any of these Inventions to others, without the express consent of PharMEDium, except as required by my
employment. 

  

	11.    (a)	I will, at any time during or after my employment, on request of PharMEDium, execute specific assignment documents in favor of PharMEDium or its nominee of my interest in and to any of the Inventions covered by this
agreement, as well as execute all papers, render all assistance, and perform all lawful acts which PharMEDium considers necessary or advisable for the preparation, filing, prosecution, issuance, procurement, maintenance or enforcement of patent
applications and patents of the United States and foreign countries for these Inventions, and for the transfer of any interest I may have therein. I will execute any and all papers and documents required to vest title in PharMEDium or its nominee in
the above Inventions, patent applications, and interests. 

  

	         (b)	I understand that if I am not employed by PharMEDium at the time I am requested to execute any document under paragraph 10(a), I shall receive fifty dollars ($50.00) for the execution of each document, and one hundred
fifty dollars ($150.00) per day of each day or portion thereof spent at the request of PharMEDium in the performance of acts pursuant to paragraph 10(a), plus reimbursement for any out-of-pocket expenses incurred by me at PharMEDium’s request
in such performance. 

  

	         (c)	I further understand that the absence of a request by PharMEDium for information, or for the making of an oath, or for the execution of any document, shall in no way be construed to constitute a waiver of
PharMEDium’s rights under this agreement. 

  
 4 

	12.	I have disclosed to PharMEDium all continuing obligations which I have with respect to the assignment of inventions to any previous employers, and I claim no previous unpatented Inventions as my own, except for those
which have been reduced to practice and which are shown on a schedule, if any, attached to this agreement. I understand that PharMEDium does not seek any confidential information which I may have acquired from a previous employer, and I will not
disclose any such information to PharMEDium. I also represent that I am not under any restrictions from a previous employer that would prevent me from working for PharMEDium and devoting my full time and effort. 

 

	13.	All writings and other works which may be copyrighted (including computer programs) which are related to the present or planned business of PharMEDium and are prepared by me during my employment by PharMEDium shall be,
to the extent permitted by law, works made for hire, and the authorship and copyright of the work shall be in PharMEDium’s name. To the extent that such writings and works are not works for hire, I agree to the waiver of “moral
rights” in such writings and works, and I hereby assign to PharMEDium all my right, title and interest in and to such writings and works, including copyright. 

 

	14.	I will permit PharMEDium and its agents to use and distribute any pictorial images which are taken of me during my employment by PharMEDium as often as desired for any lawful purpose. I waive all rights of prior
inspection or approval and release PharMEDium and its agents from any and all claims or demands which I may have on account of the lawful use or publication of such pictorial images. 

 

	15.	I understand and agree that this agreement is not a guarantee of continued employment or rate of compensation for any period. My employment is at will. This means I am free to terminate my employment at any time, for
any reason, and that PharMEDium retains the same rights. 

  

	16.	I agree to abide by the terms of the PharMEDium Employee Handbook, particularly those sections which set forth rules for conduct, and that a violation of those terms can result in discipline up to and including
discharge from employment. 

  

	17.	I understand that I may be asked to submit to drug testing as a condition of employment or continued employment and consent to such testing as determined by PharMEDium to be appropriate. 

  
 5 

	18.	The obligations which I have undertaken in paragraphs 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14 hereof shall survive the termination of my employment by PharMEDium, regardless of whether the termination is initiated by
me or PharMEDium. 

  

	19.	PharMEDium has a right to make and enforce any other rules and regulations not contrary to this agreement which will also govern my employment. 

 

	20.	PharMEDium reserves the right to contact a current or prospective employer of Employee to advise that organization of the obligations imposed by this Agreement and to prevent a breach thereof. PharMEDium may provide a
copy of this Agreement, when necessary, to prevent a violation of its terms.) 

  

	21.	The provisions of the agreement shall be severable, and in the event that any provision of it is found by any court to be unenforceable, in whole or in part, the remainder of this agreement shall nevertheless be
enforceable and binding on the parties. 

  

	22.	I agree that, to promote uniformity in the interpretation of this and similar agreements, this agreement shall be governed by the laws of Illinois for contracts made within that state. I further agree that this
agreement sets forth the essential elements of the employment agreement between PharMEDium and me. PharMEDium has the right to alter the terms of this Agreement, particularly those which are based on Company policies for conduct, pay and benefits,
without my consent but that I will receive notice of such changes. I understand that PharMEDium may, at any time and without further action by me, assign this agreement to any of its affiliated companies with which I may be employed. In the event of
such an assignment, the assignee company shall succeed to all the rights held by PharMEDium under this agreement. 

  
 6 

 (NOTE: PHARMEDIUM WILL SEEK JUDICIAL ENFORCEMENT OF ITS RIGHTS HEREUNDER, AND WILL PURSUE ALL LEGAL REMEDIES UP
TO AND INCLUDING THE PROHIBITION OF COMPETITIVE EMPLOYMENT OPPORTUNITIES. UPON LEAVING PHARMEDIUM YOUR ABILITY TO ACCEPT EMPLOYMENT WITH COMPETING ORGANIZATIONS WILL BE LIMITED.) 

Date:   4-23-13 
  

	
	EMPLOYEE
	
	/s/ William R. Spalding
	Signature
	
	William R. Spalding
	Print Name

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]